InDex Pharmaceuticals
InDex Pharmaceuticals is a biopharmaceutical company developing DIMS drugs to treat inflammatory diseases and cancer.
InDex Pharmaceuticals has raised €26M across 2 funding rounds, most recently a round in Feb 2014. Based in Solna, Sweden; founded 2007; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€26M
€26,250,000
Funding rounds
2
Investors
0
distinct backers
Active since
2011-01
latest 2014-02
Funding by year
EUR raised per yearInDex Pharmaceuticals — funding by year — interactive chart.
Data table
| InDex Pharmaceuticals — funding by year | |
|---|---|
| 2010 | €8.3M |
| 2014 | €18M |
Signals
Medium confidenceRaise-next likelihood7
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
Exit likelihood6
base rate 11% (2+ rounds)
- ▼ Old (19y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2014-02-01 | Other | €18M | — | View deal → |
| 2011-01-01 | Other | €8.3M | — | View deal → |
Similar companies
same sector or countryGlobal coverage: FundingData